Halozyme Therapeutics
HALO
#2488
Rank
โ‚ฌ5.54 B
Marketcap
43,57ย โ‚ฌ
Share price
-0.13%
Change (1 day)
19.20%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚ฌ2.01 Billion

According to Halozyme Therapeutics's latest financial reports the company's total assets are โ‚ฌ2.01 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ1.56 B-8.67%
2022-12-31โ‚ฌ1.71 B76.04%
2021-12-31โ‚ฌ0.97 B106.84%
2020-12-31โ‚ฌ0.47 B-6.66%
2019-12-31โ‚ฌ0.50 B31.26%
2018-12-31โ‚ฌ0.38 B-11.19%
2017-12-31โ‚ฌ0.43 B74.3%
2016-12-31โ‚ฌ0.24 B49.54%
2015-12-31โ‚ฌ0.16 B21.83%
2014-12-31โ‚ฌ0.13 B85.15%
2013-12-31โ‚ฌ73.7 M-27.63%
2012-12-31โ‚ฌ0.10 B101.15%
2011-12-31โ‚ฌ50.63 M-26.27%
2010-12-31โ‚ฌ68.67 M27.53%
2009-12-31โ‚ฌ53.84 M-1.67%
2008-12-31โ‚ฌ54.76 M-22.71%
2007-12-31โ‚ฌ70.85 M102.85%
2006-12-31โ‚ฌ34.93 M101.75%
2005-12-31โ‚ฌ17.31 M43.18%
2004-12-31โ‚ฌ12.09 M2252.21%
2003-12-31โ‚ฌ0.51 M133.07%
2002-12-31โ‚ฌ0.22 M645.6%
2001-12-31โ‚ฌ0.02 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ0.42 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ72.08 B 3,469.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ25.08 B 1,142.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ209.24 B 10,262.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ132.61 B 6,467.19%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ169.97 B 8,317.59%๐Ÿ‡บ๐Ÿ‡ธ USA